Immunic to participate in investor and scientific conferences in may

New york , may 6, 2024 /prnewswire/ --  immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific conferences in may: may 12-14 and 21-22: bio€quity europe 2024. jessica breu, vice president investor relations and communications at immunic, will attend and host one-on-one investor meetings at this conference taking place in san sebastiÁn, spain and virtually.
IMUX Ratings Summary
IMUX Quant Ranking